A human abuse potential study of oral Rexista
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Intellipharmaceutics International
- 26 Feb 2018 Patient gender and indication assumed.
- 26 Feb 2018 New trial record
- 19 Feb 2018 According to a an Intellipharmaceutics media release, this trial is expected to provide additional data to support the oral route of abuse-deterrent labeling claims for Rexista.